Paper Details
- Home
- Paper Details
A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania.
Author: BennettMark, ManciniCatherine, OakmanJonathan, PattersonBeth, Van AmeringenMichael
Original Abstract of the Article :
BACKGROUND: Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largely been unsuccessful. OBJECTIVE: To determine whether a dopaminergic treatment as used in tics and Tour...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.4088/JCP.09m05114gre
データ提供:米国国立医学図書館(NLM)
Trichotillomania: Taming the Hair-Pulling Beast with Olanzapine
Trichotillomania, a disorder characterized by the urge to pull out one's hair, is a complex beast that can wreak havoc on a person's life. While it's often associated with obsessive-compulsive disorders, the effectiveness of traditional treatments for obsessive-compulsive disorders hasn't been consistent in addressing trichotillomania. This study, like a determined explorer venturing into uncharted territory, investigated the use of olanzapine, a dopaminergic medication, as a potential treatment for trichotillomania. The researchers conducted a 12-week, randomized, double-blind, placebo-controlled trial with 25 participants, carefully monitoring their responses to olanzapine. Their findings showed that olanzapine was significantly more effective than placebo in reducing hair-pulling behaviors. The researchers observed a substantial improvement in the participants' condition using the Yale-Brown Obsessive Compulsive Scale for Trichotillomania (TTM-YBOCS) and the Clinical Global Impressions-Severity of Illness (CGI-S) scale.
Olanzapine: A Potential Weapon Against the Hair-Pulling Beast
This research suggests that olanzapine could be a safe and effective treatment option for trichotillomania. The results showed that olanzapine significantly improved the condition of participants compared to placebo, offering hope for those struggling with this disorder. It's important to note that this study involved a relatively small sample size and further research is needed to confirm these findings. The effectiveness of olanzapine was evident in the reduction of hair-pulling behaviors and the overall improvement in the participants' condition. The study suggests that olanzapine might provide relief for those who have been battling the hair-pulling beast for years.
Living with Trichotillomania: Finding Peace in the Storm
This research provides a glimmer of hope for those struggling with trichotillomania. While olanzapine shows promise as a potential treatment, it's important to remember that this is just one piece of the puzzle. Individuals with trichotillomania should consult with a mental health professional to create a personalized treatment plan that may involve therapy, medication, or a combination of both. It's a journey through a storm of hair-pulling urges, but with the right tools and support, a person can find peace and regain control of their life.
Dr. Camel's Conclusion
This study sheds light on the potential of olanzapine as a treatment for trichotillomania. While more research is necessary to fully understand its efficacy and long-term effects, the findings offer hope for those seeking relief from this challenging disorder. It's a reminder that even in the most difficult of conditions, there is hope and potential for healing.
Date :
- Date Completed 2011-02-16
- Date Revised 2022-03-17
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.